Target Name: MIR3065
NCBI ID: G100422915
Review Report on MIR3065 Target / Biomarker Content of Review Report on MIR3065 Target / Biomarker
MIR3065
Other Name(s): hsa-miR-3065-5p | hsa-miR-3065-3p | hsa-mir-3065 | mir-3065 | microRNA 3065 | MicroRNA 3065

MIR3065: A Potential Drug Target and Biomarker

Molecular Imaging Research has identified a potential drug target and biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MIR3065 is a heat-inducible gene that has been shown to be highly expressed in a variety of tissues and has been linked to the development and progression of several diseases. The discovery of MIR3065 as a potential drug target and biomarker has the potential to lead to new therapeutic approaches for treating these conditions.

MIR3065 is a gene that has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The MIR3065 gene has been shown to be highly expressed in a variety of tissues, including the brain, heart, liver, and muscle. The MIR3065 gene has also been shown to be involved in the development and progression of diseases such as cancer, neurodegenerative diseases, and autoimmune disorders.

One of the main advantages of MIR3065 as a potential drug target is its ability to be targeted with small molecules. This is because MIR3065 is a gene that has been shown to be involved in the development and progression of diseases, and small molecules have been shown to be effective in targeting genes that are involved in disease. The use of small molecules to target MIR3065 has the potential to lead to a new class of drugs that can be used to treat a variety of diseases.

Another advantage of MIR3065 as a potential drug target is its ability to be used as a biomarker. The MIR3065 gene has been shown to be highly expressed in a variety of tissues and has been linked to the development and progression of several diseases. This makes MIR3065 an attractive candidate for use as a biomarker for the diagnosis and treatment of diseases. By using MIR3065 as a biomarker, researchers can monitor the effectiveness of new treatments and make early detection of diseases.

In addition to its potential as a drug target and biomarker, MIR3065 has also been shown to have potential as a therapeutic agent. The use of small molecules to target MIR3065 has the potential to lead to the development of new treatments for a variety of diseases. By using MIR3065 as a therapeutic agent, researchers can target the disease at its root cause and potentially treat it more effectively.

Overall, MIR3065 is a promising candidate as a drug target and biomarker for the treatment of various diseases. Its ability to be targeted with small molecules and its potential as a therapeutic agent make it an attractive candidate for further research. As research continues, the potential of MIR3065 as a drug target and biomarker will be further evaluated, and new treatments for a variety of diseases may be discovered.

Protein Name: MicroRNA 3065

The "MIR3065 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3065 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183